Article
The contribution of cell hashing for single-cell analysis of acute leukemia
2022-09-08
Abstract excerpt
After decades during which the treatment of acute myeloblastic leukemia consisted in cytarabine + anthracycline, targeted therapies have appeared, first based on monoclonal antibodies (anti-CD52, anti-CD123) and then on specific inhibitors of molecular mutations (anti-IDH, IDH2 or FLT3). What should be the place of these therapeutic options considering the tumor heterogeneity inherent to leukemia diagnosis and the...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- aa0ecb41-bf68-5fed-a51b-545a090b65cb
- DOI
- 10.21203/rs.3.rs-1800461/v1
